"10.1371_journal.pone.0112545","plos one","2014-11-18T00:00:00Z","Jadwiga Bienkowska; Norm Allaire; Alice Thai; Jaya Goyal; Tatiana Plavina; Ajay Nirula; Megan Weaver; Charlotte Newman; Michelle Petri; Evan Beckman; Jeffrey L Browning","Translational Medicine, Biogen Idec, Cambridge, Massachusetts, United States of America; Immunobiology, Biogen Idec, Cambridge, Massachusetts, United States of America; Global Clinical Operations, Biogen Idec, Cambridge, Massachusetts, United States of America; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","Conceived and designed the experiments: JB JG TP AN MW CN MP EB JLB. Performed the experiments: JB NA AT JG TP AN MW CN MP EB JLB. Analyzed the data: JB JG TP JLB. Contributed to the writing of the manuscript: JB JG TP EB JLB.","All authors except MP were salaried employees of Biogen Idec during the conduct of these trials. JB, NA, AT, JG, TP, JO, MW and CN report being current employees of Biogen Idec with an equity interest in the company. AN, EB and JLB are former Biogen Idec employees without equity stakes. MP has received consulting fees from Biogen Idec. There are no patents or marketed products to declare and the drug remains in use in a NIH sponsored clinical study in Sjogrens disease. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","11","Jadwiga Bienkowska","JB",11,TRUE,9,11,4,NA,TRUE,TRUE,FALSE,0,NA,FALSE
